The Effect of the FDA VVarning on the Use of Droperidol by U.S. Emergency Physicians
[Article]
Richards, John R; Weiss, Steven J; Bretz, Stephen W; Schneir, Aaron B; Rinetti, Dauna; Derlet, Robert W
Objectives: To determine if emergency physicians' (EP) use droperidol has changed since the United States Food and Drug Administration (FDA) warning of December 2001 concerning QT interval prolongation, torsade de pointes, and sudden death; and to query EP opinions regarding droperidol before and after the FDA warning and regarding potential alternative drugs.
2003
Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health
4/1
Richards, John R; Weiss, Steven J; Bretz, Stephen W; Schneir, Aaron B; Rinetti, Dauna; Derlet, Robert W